TABLE 6

Pharmacokinetic parameters for DPHM in plasma CSF and ECF (n = 6 in all cases, except for the ECF concentrations in the DPHM-PRN study, where n = 3) Data are shown as mean ± S.D.



DPHM (0–4 h)

DPHM-PRN (4–8 h)

Plasma
CSF
ECF
Plasma
CSF
ECF
ClT (ml/min/kg) 29.9 ± 9.6 N.A. N.A. 36.7 ± 10.5 N.A. N.A.
Vdss (l/kg) 27.9 ± 17.4 N.A. N.A. 22.5 ± 13.5 N.A. N.A.
PB (%) 83.0 ± 2.2 N.A. N.A. 84.4 ± 10.5 N.A. N.A.
f ratio N.A. 0.40 ± 0.20 0.40 ± 0.20 N.A. 0.69 ± 0.03* 0.95 ± 0.05*
t1/2β (h)a 10.8 ± 5.4 3.6 ± 1.0 5.3 ± 4.2 7.2 ± 3.5 4.4 ± 3.4 8.3 ± 4.8
t1/2α (h)a
0.5 ± 0.2
0.6 ± 0.2
0.5 ± 0.3
0.3 ± 0.2
0.6 ± 0.3
0.9 ± 0.2#
  • PB, extent of protein binding. N.A., data not available

  • a Model-fitted parameters obtained from the two-compartment modeling of the five-step and DPHM-PRN coinfusions

  • * Significantly different from the respective DPHM value alone (unpaired t test)

  • # Significantly different from the respective five-step infusion value (paired t test)